Chemotherapy of non-small cell lung cancer according to disease extent: a meta-analysis of the literature
Authors:
- N. DonnadieuNDN. Donnadieu
- M. PaesmansMPM. Paesmans
- J.-P. SculierJSJ.-P. Sculier
- 1 August 1991
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 7 (4) , 243-252
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.Journal of Clinical Oncology, 1989
- Publication Bias and Dissemination of Clinical ResearchJNCI: Journal of the National Cancer Institute, 1989
- The New International Staging System for Lung CancerSurgical Clinics of North America, 1987
- Impact of multiple comparisons in randomized clinical trialsThe American Journal of Medicine, 1987
- Meta-Analysis in Clinical ResearchAnnals of Internal Medicine, 1987
- Meta-Analyses of Randomized Controlled TrialsNew England Journal of Medicine, 1987
- A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.Journal of Clinical Oncology, 1986
- Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium)Cancer, 1982
- Prognostic Factors for Survival in Patients With Inoperable Lung Cancer2JNCI: Journal of the National Cancer Institute, 1980